These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17690869)

  • 1. Serotonin transporter binding after recovery from eating disorders.
    Bailer UF; Frank GK; Henry SE; Price JC; Meltzer CC; Becker C; Ziolko SK; Mathis CA; Wagner A; Barbarich-Marsteller NC; Putnam K; Kaye WH
    Psychopharmacology (Berl); 2007 Dec; 195(3):315-24. PubMed ID: 17690869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.
    Bailer UF; Frank GK; Price JC; Meltzer CC; Becker C; Mathis CA; Wagner A; Barbarich-Marsteller NC; Bloss CS; Putnam K; Schork NJ; Gamst A; Kaye WH
    Psychiatry Res; 2013 Feb; 211(2):160-8. PubMed ID: 23154100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.
    Bailer UF; Frank GK; Henry SE; Price JC; Meltzer CC; Weissfeld L; Mathis CA; Drevets WC; Wagner A; Hoge J; Ziolko SK; McConaha CW; Kaye WH
    Arch Gen Psychiatry; 2005 Sep; 62(9):1032-41. PubMed ID: 16143735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
    Bailer UF; Price JC; Meltzer CC; Mathis CA; Frank GK; Weissfeld L; McConaha CW; Henry SE; Brooks-Achenbach S; Barbarich NC; Kaye WH
    Neuropsychopharmacology; 2004 Jun; 29(6):1143-55. PubMed ID: 15054474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin transporter binding after recovery from bulimia nervosa.
    Pichika R; Buchsbaum MS; Bailer U; Hoh C; Decastro A; Buchsbaum BR; Kaye W
    Int J Eat Disord; 2012 Apr; 45(3):345-52. PubMed ID: 21671458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of [11C]McN5652: a serotonin transporter radioligand.
    Szabo Z; Scheffel U; Mathews WB; Ravert HT; Szabo K; Kraut M; Palmon S; Ricaurte GA; Dannals RF
    J Cereb Blood Flow Metab; 1999 Sep; 19(9):967-81. PubMed ID: 10478648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652.
    Szabo Z; Kao PF; Scheffel U; Suehiro M; Mathews WB; Ravert HT; Musachio JL; Marenco S; Kim SE; Ricaurte GA
    Synapse; 1995 May; 20(1):37-43. PubMed ID: 7624828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced 5-HT2A receptor binding after recovery from anorexia nervosa.
    Frank GK; Kaye WH; Meltzer CC; Price JC; Greer P; McConaha C; Skovira K
    Biol Psychiatry; 2002 Nov; 52(9):896-906. PubMed ID: 12399143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depression.
    Reivich M; Amsterdam JD; Brunswick DJ; Shiue CY
    J Affect Disord; 2004 Oct; 82(2):321-7. PubMed ID: 15488265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling?
    Buchert R; Thiele F; Thomasius R; Wilke F; Petersen K; Brenner W; Mester J; Spies L; Clausen M
    J Psychopharmacol; 2007 Aug; 21(6):628-34. PubMed ID: 17092972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.
    Cannon DM; Ichise M; Fromm SJ; Nugent AC; Rollis D; Gandhi SK; Klaver JM; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2006 Aug; 60(3):207-17. PubMed ID: 16875929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography of 5-HT transporter sites in the baboon brain with [11C]McN5652.
    Szabo Z; Scheffel U; Suehiro M; Dannals RF; Kim SE; Ravert HT; Ricaurte GA; Wagner HN
    J Cereb Blood Flow Metab; 1995 Sep; 15(5):798-805. PubMed ID: 7673372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography imaging of the serotonin transporter in the pig brain using [11C](+)-McN5652 and S-([18F]fluoromethyl)-(+)-McN5652.
    Brust P; Zessin J; Kuwabara H; Pawelke B; Kretzschmar M; Hinz R; Bergman J; Eskola O; Solin O; Steinbach J; Johannsen B
    Synapse; 2003 Feb; 47(2):143-51. PubMed ID: 12454952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET.
    Shioe K; Ichimiya T; Suhara T; Takano A; Sudo Y; Yasuno F; Hirano M; Shinohara M; Kagami M; Okubo Y; Nankai M; Kanba S
    Synapse; 2003 Jun; 48(4):184-8. PubMed ID: 12687637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
    Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
    Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic neurotransmission in the living human brain: a positron emission tomography study using [¹¹C]dasb and [¹¹C]WAY100635 in young healthy men.
    Takano H; Ito H; Takahashi H; Arakawa R; Okumura M; Kodaka F; Otsuka T; Kato M; Suhara T
    Synapse; 2011 Jul; 65(7):624-33. PubMed ID: 21484882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reported childhood abuse is associated with low serotonin transporter binding in vivo in major depressive disorder.
    Miller JM; Kinnally EL; Ogden RT; Oquendo MA; Mann JJ; Parsey RV
    Synapse; 2009 Jul; 63(7):565-73. PubMed ID: 19288578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa.
    Frank GK; Kaye WH; Ladenheim EE; McConaha C
    Appetite; 2001 Aug; 37(1):9-14. PubMed ID: 11562153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of two serotonin transporter ligands in the human brain: [(11)C](+)McN5652 and [(11)C]cyanoimipramine.
    Takano A; Suhara T; Sudo Y; Inoue M; Hashimoto K; Zhang MR; Ichimiya T; Yasuno F; Suzuki K
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1289-97. PubMed ID: 12271409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.